Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05619666Not ApplicableUnknown

Acute Rehabilitation in Patients With COVID-19 Pneumonia

Role: lead

NCT03816449Not ApplicableCompleted

Influence of Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis

Role: lead

NCT04368936Completed

Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures

Role: lead

NCT04801914Unknown

Enzyme Activity of Matrix Metalloproteinases in the Serum of Patients With Malignant Obstructive Hyperbilirubinemia Before and After PTBD

Role: lead

NCT04653987Completed

The Impact of Puncture Angle on Total Fluoroscopy Time Reduction During Percutaneous Biliary Drainage

Role: lead

NCT03481764Completed

Anthropogenetic Variability in the Group of Individuals With Febrile Seizures

Role: lead

All 6 trials loaded